The GMP Cell Banking Service Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The cell banking service process includes both GMP production and Non-GMP production master cell bank. The type of GMP cell banking includes the type of services such as working cell bank (ECB), end-of-production (EOP) and research and development (R&D) cell banks. GMP cell banking service market is an emerging field. There are various tests and procedures to be followed by the service providers to a high-quality service. Many biopharmaceutical and pharmaceutical companies are very active in the field of GMP cell banking service. The ongoing worldwide research is expected to fuel the GMP cell banking service market. Within the diagnostic segment of the GMP cell banking service, most of the focus has been on the detection of contaminations and maintaining the health of cells. Most of the activity and interest of the companies is focused on the therapeutic research of the GMP cell banking service field.
The global market for GMP cell banking service market is expected to be driven by the advancement in technology of molecular and genetic studies. The key drivers of the market are the increasing cases prevalence of cancer, infectious disease and other diseases creating focus towards the requirement of more research for drug discovery. Moreover, the increasing research activities for drug development, growing research on cancer and increasing collaboration between research organizations, pharmaceutical, and biopharmaceuticals companies is also acting as a fuel to the GMP cell banking service market and is expected to drive the market within the forecast period of 2016-2026. However, the high cost of the procedures and the lack of fund can be the restraint for the growth of this market.
The number of companies developing methods to detect and modifying DNA for diagnosis and therapeutic purposes has significantly changed in recent years. The increasing investment by the pharmaceutical and biotechnology companies towards research and development is expected to drive the market. Based on the product working cell bank (ECB), master cell bank (MCB), end-of-production (EOP), virus bank and research and development (R&D) cell banks.
By end user, the global GMP Cell Banking Service market has been segmented into academic research institutes, biotechnology companies, biopharmaceutical companies, pharmaceutical companies, contract research organizations and contract manufacturing organizations. GMP cell banking service procedures are useful in many research oriented areas such as developmental biology, oncology, drug discovery and others.
By regional presence, GMP cell banking service market is segmented into five key regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America will continue to dominate the GMP cell banking service market for due to high availability of funding for research and better economic conditions. Europe is expected to hold second largest market share in global GMP cell banking service market. The growing government initiatives to support research activities and increasing number of biotechnology and biopharmaceutical companies in APAC are also driving the market for GMP cell banking service in APAC.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/13735
Some of the major players in global GMP cell banking service market include Virusure, Syngene, Sigma-Aldrich Co. LLC., WuXi AppTec, Zelle Biotechnology Private Limited, Microbiology Quality & Associates, Charles River Laboratories International, Inc., IHC World, LLC., Paragon Bioservices, Inc., Austrianova, VertMarkets, Inc. and others.
To View TOC of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/toc/13735